Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Korn

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|May 1, 1983
Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell productsJ H Korn
Clinical and Experimental Rheumatology|September 4, 2004
What's wrong with the scleroderma fibroblast?J H Korn
Arthritis and Rheumatism|March 1, 1985
Substrain heterogeneity in prostaglandin E2 synthesis of human dermal fibroblasts. Differences in prostaglandin E2 synthetic capacity of substrains are not stimulus-restrictedJ H Korn
Current Opinion in Rheumatology|December 1, 1989
Immunologic aspects of sclerodermaJ H Korn
Cellular Immunology|September 15, 1981
Modulation of lymphocyte mitogen responses by cocultured fibroblastsJ H Korn
Arthritis and Rheumatism|March 1, 1995
Diagnosis of arthritis by primary care providers versus rheumatologists: comment on the article by Chan et alJ H Korn
International Journal of Dermatology|November 1, 1980
Interaction of immune and connective tissue cellsJ H Korn
Current Opinion in Rheumatology|November 25, 2000
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesJ H Korn
Current Opinion in Rheumatology|December 1, 1991
Immunologic aspects of sclerodermaJ H Korn
Current Opinion in Rheumatology|December 1, 1990
Immunologic aspects of sclerodermaJ H Korn
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|May 1, 1983
Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell productsJ H Korn
Clinical and Experimental Rheumatology|September 4, 2004
What's wrong with the scleroderma fibroblast?J H Korn
Arthritis and Rheumatism|March 1, 1985
Substrain heterogeneity in prostaglandin E2 synthesis of human dermal fibroblasts. Differences in prostaglandin E2 synthetic capacity of substrains are not stimulus-restrictedJ H Korn
Current Opinion in Rheumatology|December 1, 1989
Immunologic aspects of sclerodermaJ H Korn
Cellular Immunology|September 15, 1981
Modulation of lymphocyte mitogen responses by cocultured fibroblastsJ H Korn
Arthritis and Rheumatism|March 1, 1995
Diagnosis of arthritis by primary care providers versus rheumatologists: comment on the article by Chan et alJ H Korn
International Journal of Dermatology|November 1, 1980
Interaction of immune and connective tissue cellsJ H Korn
Current Opinion in Rheumatology|November 25, 2000
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesJ H Korn
Current Opinion in Rheumatology|December 1, 1991
Immunologic aspects of sclerodermaJ H Korn
Current Opinion in Rheumatology|December 1, 1990
Immunologic aspects of sclerodermaJ H Korn
Pageof 9